New data shows Poland’s medical cannabis market surpasses pre-ban volumes with unexpected challenges

A recent report highlights that Poland’s medical cannabis market has not only recovered but also surpassed pre-ban volumes by 2025, revealing a robust rebound after regulatory changes. This growth was spurred by rising patient awareness and acceptance of cannabis therapeutics, alongside the government’s easing of restrictions. However, the report also indicates significant challenges, including market access disparities and lingering regulatory complexities that could impede sustained growth. While the market expansion presents promising opportunities for stakeholders, its trajectory will heavily depend on policy adaptations and infrastructure improvements. As Poland navigates this evolving landscape, potential investors and industry participants should keenly monitor regulatory developments and market trends. The findings underscore the resilience and potential of Poland’s medical cannabis sector despite past obstacles. With continued efforts to address barriers, the market is poised for further development.

Business of Cannabis